Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression in T24 human bladder cancer cells

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1673-1677

  Gai, Long ^a,b   Cai, Na ^c   Wang, Lingling ^d,e   Xu, Xiaoyi ^d   Kong, Xiangbo ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b Heilongjiang Power Hospital   (China)

^c Department of Respiratory Medicine   (China)

^d THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^e BEIHUA UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Bladder cancer; NF B; Signaling; Ursolic acid

Indexed keywords

CASPASE 3; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; URSOLIC ACID;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRITERPENES; URINARY BLADDER NEOPLASMS;

EID: 84875971626     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1364     Document Type: Article

References (29)

1. Achiwa Y, Hasegawa K, Komiya T and Udagawa Y: Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells. Oncol Rep 13: 51-57, 2005.
2. Kim KH, Seo HS, Choi HS, Choi I, Shin YC and Ko SG: Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Arch Pharm Res 34: 1363-1372, 2011.
3. Manu KA and Kuttan G: Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells. Int Immunopharmacol 8: 974-981, 2008.
4. Liu JJ, Liu WD, Yang HZ, Zhang Y, Fang ZG, Liu PQ, Lin DJ, Xiao RZ, Hu Y, Wang CZ, Li XD, He Y and Huang RW: Inactivation of PI3k/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced apoptosis in myeloid leukemia cells in vitro. Ann Hematol 89: 1089-1097, 2010.
5. Li J, Liang X and Yang X: Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. Oncol Rep 28: 501-510, 2012.
6. Shishodia S, Majumdar S, Banerjee S and Aggarwal BB: Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63: 4375-4383, 2003.
7. Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, Xing YY and Xi T: Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anticancer Drugs 20: 249-258, 2009.
8. Wu B, Wang X, Chi ZF, Hu R, Zhang R, Yang W and Liu ZG: Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway. Arch Pharm Res 35: 543-548, 2012.
9. Wang J, Li Y, Wang X and Jiang C: Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway. Basic Clin Pharmacol Toxicol 111: 106-112, 2012.
10. Wang JS, Ren TN and Xi T: Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells. Med Oncol 29: 10-15, 2012.
11. Kassi E, Papoutsi Z, Pratsinis H, Aligiannis N, Manoussakis M and Moutsatsou P: Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells. J Cancer Res Clin Oncol 133: 493-500, 2007.
12. Zhang Y, Kong C, Zeng Y, Wang L, Li Z, Wang H, Xu C and Sun Y: Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro. Mol Carcinog 49: 374-385, 2010.
13. Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Ho PC, Hui KM and Sethi G: Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med (Berl) 89: 713-727, 2011.
14. Limami Y, Pinon A, Leger DY, Pinault E, Delage C, Beneytout JL, Simon A and Liagre B: The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells. Biochimie 94: 1754-1763, 2012.
15. Tu HY, Huang AM, Wei BL, Gan KH, Hour TC, Yang SC, Pu YS and Lin CN: Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species. Bioorg Med Chem 17: 7265-7274, 2009.
16. Zheng QY, Jin FS, Yao C, Zhang T, Zhang GH and Ai X: Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Biochem Biophys Res Commun 419: 741-747, 2012.
17. Sun CH, Chang YH and Pan CC: Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder. Histopathology 58: 1054-1063, 2011.
18. Plissonnier ML, Fauconnet S, Bittard H and Lascombe I: The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL. PLoS One 6: e28354, 2011.
19. Jayasooriya RG, Choi YH, Moon SK, Kim WJ and Kim GY: Methanol extract of Hydroclathrus clathratus suppresses matrix metalloproteinase-9 in T24 bladder carcinoma cells by suppressing the NF-κB and MAPK pathways. Oncol Rep 27: 541-546, 2012.
20. Kunze D, Kraemer K, Erdmann K, Froehner M, Wirth MP and Fuessel S: Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. Int J Oncol: Jul 6, 2012 (Epub ahead of print). doi: 10.3892/ijo.2012.1549).
21. Chen CC, Cheng YY, Chen SC, Tuan YF, Chen YJ, Chen CY and Chen LC: Cyclooxygenase-2 expression is up-regulated by 2-aminobiphenyl in a ROS and MAPK-dependent signaling pathway in a bladder cancer cell line. Chem Res Toxicol 25: 695-705, 2012.
22. Yu CC, Ko FY, Yu CS, Lin CC, Huang YP, Yang JS, Lin JP and Chung JG: Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells. Int J Oncol 41: 1050-1060, 2012.
23. Lee SJ, Lim JH, Choi YH, Kim WJ and Moon SK: Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-κB-mediated MMP-9 expression inducing the MAPK pathway. Cell Signal 24: 1734-1742, 2012.
24. Takeuchi A, Eto M, Shiota M, Tatsugami K, Yokomizo A, Kuroiwa K, Itsumi M and Naito S: Sunitinib enhances antitumor effects against chemotherapy- resistant bladder cancer through suppression of ERK1/2 phosphorylation. Int J Oncol 40: 1691-1696, 2012.
25. Huang WW, Yang JS, Pai SJ, Wu PP, Chang SJ, Chueh FS, Fan MJ, Chiou SM, Kuo HM, Yeh CC, Chen PY, Tsuzuki M and Chung JG: Bufalin induces G(0)/G(1) phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells. Mutat Res 732: 26-33, 2012.
26. Weizhong Z, Shuohui G, Hanjiao Q, Yuhong M, Xiaohua Y, Jian C and Lisen L: Inhibition of cytohesin-1 by siRNA leads to reduced IGFR signaling in prostate cancer. Braz J Med Biol Res 44: 642-646, 2011.
27. Barkett M and Gilmore TD: Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18: 6910-6924, 1999.
28. Tang G, Yang J, Minemoto Y and Lin A: Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol Cell 8: 1005-1016, 2001.
29. Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ and Bedi A: p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res 58: 4531-4536, 1998.